Biogen Inc BIIB:NASDAQ (Common Stock)

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
277.12 4.18   1.53%1,079,5951.2M
Market data is delayed by at least 15 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

Chart as of 02:35 PM ET 5/25/2016

Latest News Headlines for Biogen Inc

Biogen Announces Webcast of Virtual Annual Meeting of Stockholders

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 19, 2016-- Biogen Inc. (NASDAQ: BIIB) announced today that the webcast of the Company's 2016 Annual Meeting of Stockholders will be held on Wednesday, June 8, 2016 at 9:00 a.m. Eastern Daylight Time. A live audio webcast of the meeting will be available on the Investor Relations section of the Company's corporate website at www.biogen.com/investors or directly via www.virtualshareholdermeeting.com/BIIB. An archive of the webcast will be available for replay following the meeting. Please allow at least 10 minutes prior to the event to visit the site and download the necessary software to listen to the webcast.

Biogen Announces Collaboration with University of Pennsylvania on Multiple Gene Therapy Programs

Visionary, up to $2 billion multi-year alliance to focus on development of new gene therapy and gene editing technologies and create a therapeutic platform for a broad range of diseases Biogen to team up with renowned gene therapy experts, Dr. James Wilson and Dr. Jean Bennett

View more recent headlines

Peers Information HelpBIIB Biogen Inc vs. Peers

-15.55%
BIIB
Biogen Inc
-11.87%
Shire PLC (ADR)
-21.92%
Teva Pharmaceutical Industries Ltd (ADR)
-23.95%
Mylan NV
-17.08%
Abbott Laboratories
BIIB
Biogen Inc
0.00%
Shire PLC (ADR)
0.72%
Teva Pharmaceutical Industries Ltd (ADR)
2.64%
Mylan NV
0.00%
Abbott Laboratories
2.69%
BIIB
Biogen Inc
1.53%
Shire PLC (ADR)
1.39%
-0.64%
Teva Pharmaceutical Industries Ltd (ADR)
Mylan NV
0.48%
Abbott Laboratories
1.63%
Compare these stocks

Latest Annual and Quarterly SEC Filings

More Filings
10-K

This report contains detailed information about the company's business finances and management.

10-Q

Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)

Company Background

Biogen Inc., formerly Biogen Idec Inc., is a biopharmaceutical company. The Company operates in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders segment. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for multiple sclerosis (MS), ELOCTATE for hemophilia A and ALPROLIX for hemophilia B, and FUMADERM for the treatment of severe plaque psoriasis. It also has a collaboration agreement with Genentech, Inc., a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other potential anti-CD20 therapies. It also develops late stage product candidates, including Aducanumab (BIIB037) for the treatment of Neurodegeneration, and Nusinersen for other programs.

https://www.biogen.com/

Loading...

collapse, right-facing arrow indicating collapsed view of sectionOverview

A table providing an overview of the stock
Bid | Size-- | --
Ask | Size-- | --
Price Open273.73
Previous Close272.94
Day High279.46
Day Low273.51
52 Week High6/23/2015 | 420.99
52 Week Low2/12/2016 | 242.07
% Off 52 Week High-34.17%
% Off 52 Week Low14.48%
Beta (5 Yr)0.84
Volatility Avg5/24/2016 | 40.63
10-Day Avg. Volume1,180,744
Market data is delayed by at least 15 minutes.

collapse, right-facing arrow indicating collapsed view of sectionFundamentals

A table providing the fundamentals of the stock
EPS (TTM)3/31/2016 | 16.28
P/E Ratio3/31/2016 | 15.9
Market CapLarge Cap | 60.7B
Shares Outstanding219.05M
Float218.8M

collapse, right-facing arrow indicating collapsed view of sectionDividends

A table providing information about the dividends of the stock
Dividend Yield--
Ex-Date--
Dividend Announcement--
Date of Record--
Payable-- - --
Payable Date--

collapse, right-facing arrow indicating collapsed view of sectionShare Statistics

A table providing statistics about shares of the stock
Shares Short1.95M
Short Ratio1.1
Short % of Float0.89%
As of 4/29/2016